Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 12, 1996, Pages 1961-1969

  Dolhain, Radboud J E M ^a   Van Der Heiden, Annette N ^a   Ter Haar, Natalja T ^a   Breedveld, Ferdinand C ^a   Miltenburg, André M M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERLEUKIN 2; INTERLEUKIN 4; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE; SALAZOSULFAPYRIDINE;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ANTIGENS, CD3; ANTIGENS, CD4; ARTHRITIS, RHEUMATOID; CYTOKINES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MONOCYTES; PHENOTYPE; SYNOVIAL FLUID; TH1 CELLS; TH2 CELLS;

EID: 0030459439     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391204     Document Type: Article

References (39)

1. Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H: Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A 79:3632-3636, 1982
2. Panayi GS, Lanchbury JS, Kingsley GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 35:729-735, 1992
3. Mosmann TR, Coffman RL: Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 46:111-147, 1989
4. Romagnani S: Human Th1 and Th2 subsets: doubt no more. Immunol Today 12:256-257, 1991
5. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:256-257, 1994
6. Shehadeh NN, Larosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300, 1993
7. Matyniak JE, Reiner SL: T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 181:1251-1254, 1995
8. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Röcken M: Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961-1966, 1994
9. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatury molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 80: 707-718, 1995
10. Correale J, Gilmore W, McMillan M, Li S, McCarthy K, Le T, Weiner LP: Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 154:2959-2968, 1995
11. Mahanty S, Abrams JS, King CL, Limaye AP, Nutman TB: Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol 148:3567-3571, 1992
12. Del Prete G, Tiri A, Maggi E, De Carli M, Macchia D, Parronchi P, Rossi ME, Pietrogrande M, Ricci M, Romagnani S: Defective in vitro production of γ-interferon and tumor necrosis factor-α by circulating T cells from patients with the hyper-immunoglobulin E syndrome. J Clin Invest 84:1830-1835, 1989
13. Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Simonelli C, Emmi L, De Carli M, Tiri A, Ricci M, Romagnani S: Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 146:1169-1174, 1991
14. Miltenburg AMM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC: T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 35:603-610, 1992
15. Quayle AJ, Chomarat P, Miossec P, Kjeldsen-Kragh J, Forre O, Natvig JB: Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scand J Immunol 38:75-82, 1993
16. Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A 91:8562-8566, 1994
17. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. OJM 147:393-406, 1968
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
19. Laskay T, Andersson U, Andersson J, Kiessling R, Deley M: An immunofluorescent method for identifying individual IFNγ-producing lymphocytes. J Immunol Methods 95:1-7, 1986
20. Dolhain RJEM, Andersson U, ter Haar NT, Brinkman BMN, Verweij CL, Daha MR, Breedveld FC, Miltenburg AMM: Detection of intracellular interferon-γ by light microscopy using an immunoperoxidase technique: correlation with the corresponding mRNA and protein product. J Leukocyte Biol 54:545-551, 1993
21. Van der Meide PH, Dubbeld M, Schellekens H: Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods 79:293-305, 1985
22. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gilich GJ, Silver JE: Strategies of anticytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127:5-24, 1992
23. k cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb. Eur J Immunol 13:106-111, 1983
24. Bucy RP, Panoskaltsis-Mortari A, Huang G, Li J, Karr L, Ross M, Russell JH, Murphy KM, Weaver CT: Heterogeneity of single cell cytokine gene expression in clonal T cell populations. J Exp Med 180:1251-1262, 1994
25. Iannone F, Corrigall VM, Kingsley GH, Panayi GS: Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis. Eur J Immunol 24:2706-2713, 1994
26. Salmon M, Kitas GD, Bacon PA: Production of lymphokine mRNA by CD45R+ and CD45R- helper T cells from human peripheral blood and human CD4+ T cell clones. J Immunol 143:907-912, 1989
27. Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, Shaw S: Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1)and have enhanced IFNγ production. J Immunol 140:1401-1407, 1988
28. Sanders ME, Makgoba MW, June CH, Young HA, Shaw S: Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor-mediated activation. Eur J Immunol 19:803-808, 1989
29. Conlon K, Osborne J, Morimoto C, Ortaldo JR, Young HA: Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes. Eur J Immunol 25:644-648, 1995
30. Bettens F, Walker C, Cauchat JF, Cauchat D, Wyss T, Pichler WJ: Lymphokine gene expression related to CD4 T cell subset (CD45R/CDw29) phenotype conversion. Eur J Immunol 19:1569-1574, 1989
31. Andersson U, Andersson J, Lindfors A, Wagner K, Möller G, Heusser CH: Simultaneous production of interleukin 2, interleukin 4 and interferon-γ by activated human blood lymphocytes. Eur J Immunol 20:1591-1596, 1990
32. Firestein GS, Zvaifler NJ: How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33:768-773, 1990
33. Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 52:S39-S47, 1993
34. Halloran PF: Interferon-γ, prototype of the proinflammatory cytokines: importance in activation, suppression, and maintenance of the immune response. Transplant Proc 25 (suppl 1):10-15, 1993
35. Firestein GS, Zvaifler NJ: Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. I. A cytofluorographic study of monocyte differentiation antigens and class II antigens and their regulation by γ-interferon. Arthritis Rheum 30:857-863, 1987
36. Seder RA, Paul WE, Davis MM, Fazekas de St. Groth B: The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med 176:1091-1098, 1992
37. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517-1527, 1994
38. Allen JB, Wong HL, Costa GL, Bienkowski MJ, Wahl SM: Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 151:4344-4351, 1993
39. Van den Berg WB, Joosten LAB, Jacobs M, Helsen MA, Durez P, Delvaux A, Velu T, Goldman M: Suppression of established collagen-induced arthritis with IL-4 and IL-10 (abstract). Arthritis Rheum 37 (suppl 9):S280, 1994